Method for quantitatively controlling plasmid copy number in antibiotic-free plasmid maintenance system

Patent metadata

Field	Value
Publication number	US-12247242-B2
Application number	US-201816500637-A
Country	US
Kind code	B2
Filing date	Apr 5, 2018
Priority date	Apr 6, 2017
Publication date	Mar 11, 2025
Grant date	Mar 11, 2025

Abstract

The present invention relates to a gene expression cassette including a synthetic 5′ untranslated region (5′ UTR), a promoter, and a regulatory gene; a recombinant vector including a replication origin and the gene expression cassette; a recombinant microorganism which has the recombinant vector introduced thereinto and shows alleviated segregational instability and; a method for preparing a recombinant microorganism having alleviated segregational instability by introducing the recombinant vector thereinto; and a method for quantitatively controlling a plasmid copy number in a recombinant microorganism. According to the present invention, removal of infA and efp, which are genes indispensable for cells, encoding respectively for a translation initiation factor and a protein elongation factor (EF-P), from a microbial chromosome and introduction of the gene expression cassette including the regulatory gene with Escherichia coli serving as a host allow the stable maintenance of plasmids in an antibiotic-free medium without causing intercellular intrinsic variations. In addition, the precise control of expression levels of infA and efp in the recombinant microorganism by means of a promoter can lead to the quantitative control of PCN at high yield as well. Therefore, the present invention can find a broad spectrum of applications in a variety of industries producing recombinant proteins.

First claim

The invention claimed is:

1. A gene expression cassette containing a synthetic 5′ UTR (untranslated region), a promoter, and a regulatory gene, wherein the synthetic 5′ UTR includes one 5′ UTR selected from a group consisting of SEQ ID NOs: 54, 55, 56 and 59.

2. The gene expression cassette of claim 1 , wherein the regulatory gene includes at least one selected from a group consisting of iiribF, ileS, IspA, ispH, dapB, folA, imp, ftsL, ftsI, murE, murF, mraY, murD, ftsW, murG, murC, ftsQ, ftsA, ftsZ, IpxC, secM, secA, coaE, can, folk, hemL, yadR, dapD, map, rpsB, tsf, pyrH, frr, dxr, ispU, cdsA, yaeL, yaeT, lpxD, fabZ, lpxA, lpxB, dnaE, accA, tilS, proS, hemB, secD, secF, ribD, ribE, nusB, thiL, dxs, ispA, ffs, dnaX, adk, hemH, lpxH, cysS, folD, argU mrdB, mrdA, nadD, holA, rlpB, leuS, lnt, leuW, glnS, fldA, infA, ftsK, lolA, serS, rpsA, msbA, lpxK, kdsB, mukF, mukE, mukB, asnS, fabA, serT, mviN, me, yceQ, fabD, fabG, acpP, tmk, holB, lolC, lolD, lolE, pth, prsA, ispE, lolB, hemA, prfA, prmC, kdsA, topA, ribA, fabI, tyrS, ribC, pheT, pheS, rplT, infC, thrS, nadE, gapA, yeaZ, aspS, argS, leuZ, cysT, pgsA, metG, folE, vejM, gyrA, nrdA, nrdB, folC, accD, fabB, gltX, ligA, zipA, dapE, dapA, hda, der, hisS, ispG, suhB, acpS, era, lepB, pssA, yfiO, rplS, trmD, rpsP, ffh, grpE, yfjB, serV, csrA, alaS, ispF, ispD, ftsB, eno, pyrG, lgt, prfB, fbaA, pgk, metK, vqgF, plsC, parC, parE, ribB, cca, folB, ygjD, dnaG, rpoD, infB, nusA, leuU, glmM, ftsH, obgE, rpmA, rplU, ispB, murA, kdsC, yrbK, yhbN, yhbG, rpsI, rplM, degS, mreD, mreC, mreB, accB, accC, rpoC, rpoB, rplL, rplJ, nusG, secE, glyT, thrU, coaA, birA, murB, murI, priA, ftsN, yihA, polA, hemG, hemC, hemD, proM, hisR, argX, rho, trpT, glmU, glmS, yidC, mpA, rpmH, dnaA, dnaN, gyrB, spoT, gmk, dut, dfp, rpmB, coaD, kdtA, gpsA, glyQ, glyS, ftsY, ftsE, ftsX, rpoH, asd, yrfF, trpS, rpsL, rpsG, fusA, rpsJ, rplC, rplD, rplW, rplB, rpsS, rplV, rpsC, rplP, rpmC, rpsQ, rplN, rplX, rplE, rpsN, rpsH, rplF, rplR, rpsE, rpmD, rplO, secY, rpsM, rpsK, rpsD, rpoA, rplQ, fmt, def, yrdC, ubiA, plsB, lexA, dnaB, ssb, groS, groL, efp, psd, rsgA, orn, yjeE, rpsR, ppa, valS, yjgP, yjgQ, dnaC and dnaT.

3. The gene expression cassette of claim 1 , wherein the promoter includes one promoter selected from a group consisting of SEQ ID NOS: 1 to 5.

4. The gene expression cassette of claim 1 , wherein the synthetic 5′ UTR is configured to down-regulate a gene.

5. The gene expression cassette of claim 1 , wherein the gene expression cassette further includes a target gene.

6. The gene expression cassette of claim 5 , wherein the target gene includes an itaconic acid or lycopene-producing gene.

7. The gene expression cassette of claim 1 , wherein the gene expression cassette further includes a terminator.

8. The gene expression cassette of claim 7 , wherein the terminator consists of SEQ ID NO: 53.

9. A recombinant vector comprising a replication origin and the gene expression cassette of claim 1 .

10. The recombinant vector of claim 9 , wherein the recombinant vector is a plasmid.

11. The recombinant vector of claim 10 , wherein the plasmid includes the replication origin to allow the plasmid to have 1 to 600 copy numbers per cell.

12. The recombinant vector of claim 9 , wherein the recombinant vector includes CloDF-13 or PMB1 as the replication origin and includes infA as the regulatory gene.

13. The recombinant vector of claim 9 , wherein the recombinant vector includes CloE1 as the replication origin and includes efp as the regulatory gene.

14. A recombinant microorganism having alleviated segregational instability (segregational instability), wherein the recombinant microorganism has the recombinant vector of claim 9 introduced thereto.

15. A recombinant microorganism having alleviated segregational instability (segregational instability), wherein the recombinant microorganism has one or more recombinant vectors introduced thereto selected from a group consisting of the recombinant vector of claim 12 and the recombinant vector of claim 13 .

16. The recombinant microorganism having alleviated segregational instability (segregational instability) of claim 14 , wherein the recombinant microorganism stably maintains the number of the recombinant vectors therein.

17. The recombinant microorganism having alleviated segregational instability (segregational instability) of claim 14 , wherein one or more regulatory genes selected from a group consisting of iiribF, ileS, IspA, ispH, dapB, folA, imp, ftsL, ftsI, murE, murF, mraY, murD, ftsW, murG, murC, ftsQ, ftsA, ftsZ, IpxC, secM, secA, coaE, can, folk, hemL, yadR, dapD, map, rpsB, tsf, pyrH, frr, dxr, ispU, cdsA, yaeL, yaeT, lpxD, fabZ, lpxA, lpxB, dnaE, accA, tilS, proS, hemB, secD, secF, ribD, ribE, nusB, thiL, dxs, ispA, ffs, dnaX, adk, hemH, lpxH, cysS, folD, argU, mrdB, mrdA, nadD, holA, rlpB, leuS, lnt, leuW, glnS, fldA, infA, ftsK, lolA, serS, rpsA, msbA, lpxK, kdsB, mukF, mukE, mukB, asnS, fabA, serT, mviN, me, yceQ, fabD, fabG, acpP, tmk, holB, lolC, lolD, lolE, pth, prsA, ispE, lolB, hemA, prfA, prmC, kdsA, topA, ribA, fabI, tyrS, ribC, pheT, pheS, rplT, infC, thrS, nadE, gapA, yeaZ, aspS, argS, leuZ, cysT, pgsA, metG, folE, vejM, gyrA, nrdA, nrdB, folC, accD, fabB, gltX, ligA, zipA, dapE, dapA, hda, der, hisS, ispG, suhB, acpS, era, lepB, pssA, yfiO, rplS, trmD, rpsP, ffh, grpE, yfjB, serV, csrA, alaS, ispF, ispD, ftsB, eno, pyrG, lgt, prfB, fbaA, pgk, metK, yqgF, plsC, parC, parE, ribB, cca, folB, ygjD, dnaG, rpoD, infB, nusA, leuU, glmM, ftsH, obgE, rpmA, rplU, ispB, murA, kdsC, yrbK, yhbN, yhbG, rpsI, rplM, degS, mreD, mreC, mreB, accB, accC, rpoC, rpoB, rplL, rplJ, nusG, secE, glyT, thrU, coaA, birA, murB, murI, priA, ftsN, yihA, polA, hemG, hemC, hemD, proM, hisR, argX, rho, trpT, glmU, glmS, vidC, mpA, rpmH, dnaA, dnaN, gyrB, spoT, gmk, dut, dfp, rpmB, coaD, kdtA, gpsA, glyQ, glyS, ftsY, ftsE, ftsX, rpoH, asd, yrfF, trpS, rpsL, rpsG, fusA, rpsJ, rplC, rplD, rplW, rplB, rpsS, rplV, rpsC, rplP, rpmC, rpsQ, rplN, rplX, rplE, rpsN, rpsH, rplF, rplR, rpsE, rpmD, rplO, secY, rpsM, rpsK, rpsD, rpoA, rplQ, fmt, def, yrdC, ubiA, plsB, lexA, dnaB, ssb, groS, groL, efp, psd, rsgA, orn, yjeE, rpsR, ppa, valS, yjgP, yjgQ, dnaC and dnaT on chromosomes in the recombinant microorganism are removed.

18. A method for preparing a recombinant microorganism having alleviated segregational instability (segregational instability), the method comprising introducing the recombinant vector of claim 9 thereto.

Assignees

• Postech Acad Ind Found
• Seoul Nat Univ R&Db Foundation
• Seoul Nat Univ R&Db Foundation

Inventors

• Jung Gyoo Yeol
• Seo Sang Woo
• Kang Chae Won
• Lim Hyun Gyu

Classifications

• C12P5/026

  Unsaturated compounds, i.e. alkenes, alkynes or allenes · CPC title

• C12N2840/10

  regulates levels of translation · CPC title

• C12N2830/36

  being a transcription termination element · CPC title

• C12N2800/101

  for bacteria · CPC title

• C12N15/70 Primary

  Vectors or expression systems specially adapted for E. coli · CPC title